We used other cell lines (2 gastric cancer cell lines and 1 hepatocellular cancer cell line) to accurately determine the contribution of the p53 pathway to apoptosis induced by CDDP in combination with epigenetic treatments. The gene discussed is TP53; the disease is gastric cancer.